NCT04921527 2024-10-18
CHIPRO
Chipscreen Biosciences, Ltd.
Phase 3 Recruiting
Clinical Trials
4 trialsNCT03901118 2021-03-19
Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer
Chipscreen Biosciences, Ltd.
Phase 2 Completed
NCT03166891 2020-01-18
Phase Ib Study of Chiauranib in Patients With Ovarian Cancer
Chipscreen Biosciences, Ltd.
Phase 1/2 Completed
NCT03074825 2019-07-24
Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma
Chipscreen Biosciences, Ltd.
Phase 1 Terminated